Transplant rejection poses a significant challenge in organ transplantation. The immune system's response to foreign tissue can lead to three types of rejection: hyperacute, acute, and chronic. Each type has distinct mechanisms, timelines, and clinical manifestations.
Understanding these rejection types is crucial for successful transplantation. Prevention strategies, such as careful donor-recipient matching and immunosuppression, along with prompt management of rejection episodes, are key to improving graft survival and patient outcomes.
Types of Transplant Rejection
Types of transplant rejection
- Hyperacute rejection occurs within minutes to hours after transplantation mediated by preformed antibodies in recipient's blood rapidly attacking donor tissue (kidney, heart)
- Acute rejection develops days to weeks post-transplantation involving T-cell mediated response against donor antigens leading to inflammation and organ dysfunction (liver, lung)
- Chronic rejection occurs months to years after transplantation causing gradual decline in graft function due to ongoing immune responses resulting in fibrosis (cornea, blood vessels)
Mechanisms of rejection
- Hyperacute rejection
- Preexisting antibodies bind donor endothelial cells triggering complement activation
- Rapid thrombosis forms in blood vessels
- Neutrophils infiltrate causing extensive tissue damage
- Acute rejection
- T cells recognize donor MHC molecules as foreign
- CD4+ T helper cells activate macrophages and B cells amplifying immune response
- CD8+ cytotoxic T cells directly attack graft cells causing apoptosis
- Activated B cells produce antibodies against donor antigens
- Chronic rejection
- Persistent low-grade inflammation damages graft over time
- Alloantibody production against donor HLA molecules
- Fibrosis and tissue remodeling alter organ structure
- Vascular changes lead to ischemia and progressive dysfunction
Clinical signs of rejection
- Hyperacute rejection
- Immediate graft failure within minutes to hours post-transplant
- Cyanosis and mottling of transplanted organ indicate lack of blood flow
- Absence of blood flow in imaging studies (ultrasound, angiography)
- Acute rejection
- Onset within days to weeks after transplantation
- Fever, malaise, and graft tenderness signal immune activation
- Organ-specific dysfunction (elevated creatinine in kidney transplants, increased liver enzymes)
- Biopsy shows cellular infiltration and tissue damage confirming diagnosis
- Chronic rejection
- Gradual onset months to years post-transplant
- Progressive decline in graft function detected through lab tests
- Fibrosis and scarring of transplanted organ visible on imaging
- Organ-specific manifestations (bronchiolitis obliterans in lung transplants, coronary artery disease in heart transplants)
Prevention and management strategies
- Prevention strategies
- Careful donor-recipient matching (ABO blood type, HLA typing) to minimize immunological differences
- Pre-transplant crossmatching detects preformed antibodies avoiding hyperacute rejection
- Immunosuppressive induction therapy at time of transplantation prevents early rejection
- Management of hyperacute rejection
- Limited treatment options due to rapid onset and severe damage
- Immediate graft removal if detected to prevent systemic complications
- Plasmapheresis removes circulating antibodies potentially salvaging graft
- Management of acute rejection
- High-dose corticosteroids as first-line treatment suppress inflammation
- T cell-depleting antibodies (antithymocyte globulin) for steroid-resistant cases
- Adjustment of maintenance immunosuppression regimen (tacrolimus, mycophenolate)
- Management of chronic rejection
- Regular monitoring of graft function through lab tests and imaging
- Optimization of immunosuppression balancing rejection risk and side effects
- Treatment of comorbidities (hypertension, hyperlipidemia) to protect graft function
- Consideration of retransplantation in advanced cases when graft failure is imminent
- Long-term strategies
- Patient education on medication adherence emphasizing importance of immunosuppression
- Regular follow-up and monitoring for signs of rejection (lab tests, biopsies)
- Minimization of immunosuppression-related side effects (infections, malignancies) through careful dosing